June 15, 2026- Medtronic plc announced it has completed its acquisition of Scientia Vascular, a privately-held medical device company in Salt Lake City. The acquisition is valued at $550 million, subject to customary adjustments, with potential undisclosed earn-out and milestone payments post-acquisition.
Scientia has developed best-in-class access products that enable simplicity and access for physicians treating complex neurovascular conditions. Scientia’s portfolio of guidewires and catheters can be seamlessly integrated with Medtronic’s existing suite of neurovascular products, strengthening the company’s ability to support physicians across the full procedural workflow.
This acquisition reflects Medtronic’s continued focus on strategic deals that strengthen its leadership across core businesses. The company remains committed to pursuing high-growth opportunities that complement its portfolio and enhance value for physicians and hospital partners.